5D Clinics NSW Team

Dr Joe Chang is an experienced Radiation Oncologist committed to delivering evidence-based and patient-centred cancer care. His honest and engaging approach ensures patients and their families feel informed and supported throughout treatment and beyond. His clinical experience spans a broad range of malignancies, with particular interests in genitourinary, brain and spinal (CNS), lung and skin cancers, sarcoma, and stereotactic radiotherapy.

Dr Chang completed specialist radiation oncology training at Peter MacCallum Cancer Centre and undertook a fellowship in stereotactic ablative body radiotherapy (SABR) and intracranial stereotactic radiosurgery (SRS) at Sunnybrook Odette Cancer Centre in Toronto, Canada. He was awarded a PhD from the University of Melbourne in 2015.

Actively involved in clinical research, Dr Chang chairs the Sydney SABR Consortium and contributes to multidisciplinary cancer care across Sydney. He has a strong interest in precision radiation therapies and remains dedicated to improving outcomes through innovation, research and compassionate care.

Dr Anupam Chaudhuri is an experienced Radiation Oncologist committed to delivering prompt, personalised and patient-focused cancer care. His clinical experience spans a broad range of solid tumour malignancies, with particular interests in prostate, brain, lung and skin cancers. He also has specialist expertise in stereotactic ablative body radiotherapy (SABR) and stereotactic radiosurgery (SRS), helping patients access highly targeted treatment options.

Dr Chaudhuri completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) at the University of Calcutta before undertaking specialist oncology training at Nottingham University Hospital and Velindre Cancer Centre in Cardiff. He is a Fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) and a Member of the Royal College of Physicians (UK).

With extensive international experience across the United Kingdom, United States, New Zealand and Australia, Dr Chaudhuri combines clinical expertise with an active interest in research and multidisciplinary cancer care. He is dedicated to improving patient outcomes through evidence-based treatment and compassionate support throughout every stage of care.

Dr Andrew Fong is an experienced Radiation Oncologist who brings a personalised and patient-focused approach to cancer care. Known for his clear communication and compassionate manner, he tailors treatment to the individual needs of each patient. His clinical interests include breast, lung and head and neck cancers, as well as stereotactic radiation therapy and stereotactic ablative body radiotherapy (SABR).

Dr Fong graduated from the University of New South Wales and completed specialist training at Prince of Wales Hospital and Royal North Shore Hospital. He became a Fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2009 and later completed a Master of Electronic Healthcare at the University of Queensland, receiving the Dean’s Commendation for High Achievement.

Actively involved in research, education and clinical leadership, Dr Fong is Clinical Director of Radiation Oncology at Sydney Adventist Hospital and Chair of the Icon Australasia Lung and Body Stereotactic Clinical Stream. He remains committed to advancing precision cancer treatment and delivering exceptional patient care.

Dr Leily Rezaei is an experienced Radiation Oncologist with a clinical focus on Prostate and male genitourinary cancers, Liver and Pancreas tumours, and stereotactic body radiation therapy (SBRT).

After graduating from SBUMS University of Medical Sciences in Tehran, Dr Rezaei moved to Sydney and commenced her medical career as a resident at Royal Prince Alfred Hospital in 2005. She completed specialist training in radiation oncology across several leading cancer centres, including Prince of Wales, Liverpool, Wollongong and St George hospitals, before undertaking a post-graduate fellowship at Royal Prince Alfred Hospital and Chris O’Brien Lifehouse.

Dr Rezaei was appointed as a Staff Specialist at Chris O’Brien Lifehouse in 2015 and has subspecialty interests in prostate and male genitourinary cancer, upper gastrointestinal tumours, and stereotactic body radiation therapy (SBRT).

She is a member of the ANZUP prostate subcommittee, AGITG and TROG, and leads multiple national and international clinical trials focused on prostate and upper gastrointestinal cancers at Chris O’Brien Lifehouse.

She is committed to delivering evidence-based, patient-centred care while advancing treatment outcomes through clinical research and innovation.

Dr Johnson Lam is an experienced Radiation Oncologist committed to achieving the best outcomes for his patients through an evidence-based, caring and compassionate approach to cancer care. His clinical experience spans a broad range of solid tumour malignancies, with particular interests in breast, prostate, gastrointestinal, lung and skin cancers.

Dr Lam completed his Bachelor of Medicine at the University of Newcastle and undertook specialist radiation oncology training across the Northern NSW Advanced Training Network. He became a Fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2019 and completed a fellowship in advanced imaging at Royal North Shore Hospital, developing a particular interest in the use of PET imaging in oncology.

Actively involved in research, teaching and advanced radiation techniques, Dr Lam is dedicated to delivering personalised treatment and high-quality patient care. Fluent in both English and Cantonese, he is passionate about supporting patients and their loved ones throughout every stage of treatment.

Dr Mark Lee is a senior Radiation Oncologist dedicated to delivering comprehensive, personalised cancer care. He combines extensive clinical expertise with a strong research background to provide evidence-based treatment tailored to each patient. His clinical experience spans a broad range of solid tumour malignancies, with particular interests in gastrointestinal, liver, head and neck, and skin cancers, as well as re-irradiation, palliative care and stereotactic radiation therapy.

Dr Lee completed a Master of Science at the University of Toronto and undertook fellowship training in stereotactic body radiation therapy for liver cancer at Princess Margaret Hospital in Canada. He has extensive experience in advanced radiation techniques, including stereotactic radiotherapy for liver, pancreatic and other abdominal tumours.

Actively involved in research, clinical trials and medical education, Dr Lee remains committed to advancing cancer treatment and improving patient outcomes. He is recognised for his expertise in precision radiation therapies and his contributions to multidisciplinary cancer care.

Dr David Newsome is a Canberra based Radiation Oncologist dedicated to providing personalised, evidence-based cancer care for patients across Canberra and Southern New South Wales. He has experience treating a broad range of tumour types, with particular interests in prostate cancer, skin cancer and stereotactic radiotherapy.

Dr Newsome completed a Bachelor of Science in Physiology and Neuroscience before earning his medical degree at Monash University. He undertook radiation oncology training through Canberra Health Services and has worked across both public and private healthcare settings, providing advanced radiation therapy services to metropolitan and regional communities.

Dr Newsome has a strong interest in stereotactic radiotherapy and innovative treatment approaches, including access to advanced technologies and radiation techniques. He is active in Multidisciplinary Teams through Canberra Health Services, is involved in teaching at Australian National University and holds a strong interest in mentoring Radiation Oncology Trainees. Born and raised in Canberra, he is able to offer consultations at Icon Cancer Centre Canberra to serve the ACT and Southern NSW region, with access to CyberKnife services in 5D Clinics Sydney.

Dr Apsara Windsor is a senior Radiation Oncologist committed to delivering personalised, evidence-based cancer care. She has extensive experience treating a broad range of malignancies, with particular interests in breast and gastrointestinal cancers, stereotactic radiation therapy for oligometastatic disease, and liver malignancies. She works closely with multidisciplinary teams to develop tailored treatment plans that support the best possible outcomes for her patients.

Dr Windsor completed her medical degree with Honours at the University of New South Wales and undertook specialist radiation oncology training at Prince of Wales, Westmead, Nepean and Liverpool Hospitals. She completed a clinical research fellowship at Liverpool Hospital and became a Fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2011.

A recognised leader in radiation oncology, Dr Windsor is a Senior Lecturer at the University of Newcastle and currently serves as Chief Censor of the Faculty of Radiation Oncology, RANZCR. She remains actively involved in clinical research, education, quality improvement and advancing patient-centred cancer care.

Dr Angela Yates is a compassionate and dedicated Radiation Oncologist committed to delivering high quality, evidence-based cancer care. Her clinical experience spans a broad range of solid tumour malignancies, with particular interests in breast and prostate cancer, skin and lung malignancies, central nervous system and gastrointestinal cancers, haematological malignancies, and stereotactic radiation therapy.
 

Dr Yates has extensive experience in multidisciplinary cancer care and advanced radiation techniques, working closely with patients and referring specialists to develop personalised treatment plans. She is actively involved in clinical research and is passionate about advancing cancer treatment through innovation and evidence-based practice.   

With a strong interest in stereotactic radiation therapy and precision treatment technologies, Dr Yates is committed to improving outcomes while minimising the impact of treatment on patients’ quality of life. Through both her clinical and research work, she remains dedicated to delivering exceptional patient-centred care.